Preparation and evaluation of liver-targeting micelles loaded with oxaliplatin

Artificial Cells, Nanomedicine and Biotechnology

Volumn 44, Issue 2, 2016, Pages 491-496

  Yan, Guowen ^a   Chen, Qian ^a   Xu, Lisa ^a   Wei, Haitian ^a   Ma, Chao ^a   Sun, Yong ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Nanoparticle; Oxaliplatin; Pharmacokinetics; Tumor

Indexed keywords

CONJUGATED POLYMERS; ENCAPSULATION; NANOPARTICLES; PHARMACOKINETICS; TUMORS;

ENCAPSULATION EFFICIENCY; GLYCYRRHETINIC ACIDS; LIVER TARGETING; LIVER-TARGETED DELIVERIES; OXALIPLATIN; POLYMER-MODIFIED; TARGETED DELIVERY; UNIFORM SIZE;

MICELLES;

CHITOSAN; DISTILLED WATER; GLYCYRRHETINIC ACID; ORGANIC SOLVENT; OXALIPLATIN; STEARIC ACID; DRUG CARRIER; MICELLE; PLATINUM COMPLEX; STEARIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; DRUG TARGETING; ENCAPSULATION; HEART; KIDNEY; LIVER; LIVER TARGETING; LIVER TARGETING MICELLE; LUNG; MICELLE; MORPHOLOGY; MOUSE; NONHUMAN; PARTICLE SIZE; SPLEEN; ANIMAL; CHEMISTRY; METABOLISM; TISSUE DISTRIBUTION;

ANIMALS; CHITOSAN; DRUG CARRIERS; DRUG LIBERATION; GLYCYRRHETINIC ACID; LIVER; MICE; MICELLES; ORGANOPLATINUM COMPOUNDS; STEARIC ACIDS; TISSUE DISTRIBUTION;

EID: 84964374836     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2014.962747     Document Type: Article

References (9)

1. Chen Q, Sun Y, Wang J, Yan G, Cui Z, Yin H, Wei H. 2013. Preparation and characterization of glycyrrhetinic acid-modified stearic acid-grafted chitosan micelles. Artif Cells Nanomed Biotechnol. doi:10.3109/2169-1401.2013.845570.
2. Hostetter AA, Osborn MF, DeRose VJ 2012. RNA-Pt adducts formed from cisplatin treatment of Saccharomyces cerevisiae. ACS Chem Biol. 7:218-225.
3. King CL, Ramachandran S, Chaney SG, Collins L, Swenberg JA, DeKrafft KE, et al 2012. Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells. Cancer Chemother Pharmacol. 69:666-677.
4. Melgar MJ, Alonso J, García MA. 2014. Total contents of arsenic and associated health risks in edible mushrooms, mushroom supplements and growth substrates from Galicia (NW Spain). Food Chem Toxicol. 73C:44-50.
5. Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC 2011. Dose effects of-oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity. PLoS ONE. 6:e18469.
6. Sittl R, Lampert A, Huth T, Schuy ET, Link AS, Fleckenstein J, et al 2012. Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype NaV1.6-resurgent and persistent current. Proc Natl Acad Sci. 109:6704-6709.
7. Wang K, Liu L, Zhang T, Zhu YL, Qiu F, Wu XG, et al 2011. Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer. Int J Nanomedicine. 6:3207-3218.
8. Wei H, Xu L, Sun Y, Li G, Cui Z, Yan G, et al 2014. Preliminary pharmacokinetics of PEGylated oxaliplatin polylactic acid nanoparticles in rabbits and tumor-bearing mice. Artif Cells Nanomed Biotechnol. doi:10.3109/21691401.2014.883402.
9. Weidmann AG, Barton JK 2014. Construction and application of a rh-pt DNA metalloinsertor conjugate. Inorg Chem. 53: 7812-7814.